Selected research
Industry Research
Infectious Substance Packaging Industry Research Report 2026
Market perspective
The global Infectious Substance Packaging market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Infectious Substance Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Infectious Substance Packaging is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Infectious Substance Packaging is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Infectious Substance Packaging include Air Sea Containers, CIBESMED Ltd, ALEX BREUER GMBH, E3 Cortex, Berlin Packaging LLC, CFT Canada, ICC, Therapak™ and Serpac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Infectious Substance Packaging market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Infectious Substance Packaging Market by Company
Air Sea Containers
CIBESMED Ltd
ALEX BREUER GMBH
E3 Cortex
Berlin Packaging LLC
CFT Canada
ICC
Therapak™
Serpac
Friobox
Infectious Substance Packaging Segment by Type
UN2814
UN2900
UN3373
Others
Infectious Substance Packaging Segment by Application
Healthcare and Medical Laboratories
Pharmaceutical Industry
Veterinary Medicine
Hazardous Waste Management
Infectious Substance Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infectious Substance Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Infectious Substance Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infectious Substance Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Infectious Substance Packaging manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Infectious Substance Packaging by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Infectious Substance Packaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- UN2814
- UN2900
- UN3373
- Others
Applications
- Healthcare and Medical Laboratories
- Pharmaceutical Industry
- Veterinary Medicine
- Hazardous Waste Management
Companies covered
- Air Sea Containers
- CIBESMED Ltd
- ALEX BREUER GMBH
- E3 Cortex
- Berlin Packaging LLC
- CFT Canada
- ICC
- Therapak™
- Serpac
- Friobox
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Infectious Substance Packaging Market Size (2021-2032)
- 2.2.2 Global Infectious Substance Packaging Sales (2021-2032)
- 2.2.3 Global Infectious Substance Packaging Market Average Price (2021-2032)
- 2.3 Infectious Substance Packaging by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 UN2814
- 2.3.3 UN2900
- 2.3.4 UN3373
- 2.3.5 Others
- 2.4 Infectious Substance Packaging by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Healthcare and Medical Laboratories
- 2.4.3 Pharmaceutical Industry
- 2.4.4 Veterinary Medicine
- 2.4.5 Hazardous Waste Management
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Infectious Substance Packaging Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Infectious Substance Packaging Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Infectious Substance Packaging Revenue of Manufacturers (2021-2026)
- 3.4 Global Infectious Substance Packaging Average Price by Manufacturers (2021-2026)
- 3.5 Global Infectious Substance Packaging Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Infectious Substance Packaging, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Infectious Substance Packaging, Product Type & Application
- 3.8 Global Manufacturers of Infectious Substance Packaging, Established Date
- 3.9 Global Infectious Substance Packaging Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Air Sea Containers
- 4.1.1 Air Sea Containers Company Information
- 4.1.2 Air Sea Containers Business Overview
- 4.1.3 Air Sea Containers Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Air Sea Containers Infectious Substance Packaging Product Portfolio
- 4.1.5 Air Sea Containers Recent Developments
- 4.2 CIBESMED Ltd
- 4.2.1 CIBESMED Ltd Company Information
- 4.2.2 CIBESMED Ltd Business Overview
- 4.2.3 CIBESMED Ltd Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CIBESMED Ltd Infectious Substance Packaging Product Portfolio
- 4.2.5 CIBESMED Ltd Recent Developments
- 4.3 ALEX BREUER GMBH
- 4.3.1 ALEX BREUER GMBH Company Information
- 4.3.2 ALEX BREUER GMBH Business Overview
- 4.3.3 ALEX BREUER GMBH Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ALEX BREUER GMBH Infectious Substance Packaging Product Portfolio
- 4.3.5 ALEX BREUER GMBH Recent Developments
- 4.4 E3 Cortex
- 4.4.1 E3 Cortex Company Information
- 4.4.2 E3 Cortex Business Overview
- 4.4.3 E3 Cortex Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 E3 Cortex Infectious Substance Packaging Product Portfolio
- 4.4.5 E3 Cortex Recent Developments
- 4.5 Berlin Packaging LLC
- 4.5.1 Berlin Packaging LLC Company Information
- 4.5.2 Berlin Packaging LLC Business Overview
- 4.5.3 Berlin Packaging LLC Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Berlin Packaging LLC Infectious Substance Packaging Product Portfolio
- 4.5.5 Berlin Packaging LLC Recent Developments
- 4.6 CFT Canada
- 4.6.1 CFT Canada Company Information
- 4.6.2 CFT Canada Business Overview
- 4.6.3 CFT Canada Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 CFT Canada Infectious Substance Packaging Product Portfolio
- 4.6.5 CFT Canada Recent Developments
- 4.7 ICC
- 4.7.1 ICC Company Information
- 4.7.2 ICC Business Overview
- 4.7.3 ICC Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ICC Infectious Substance Packaging Product Portfolio
- 4.7.5 ICC Recent Developments
- 4.8 Therapak™
- 4.8.1 Therapak™ Company Information
- 4.8.2 Therapak™ Business Overview
- 4.8.3 Therapak™ Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Therapak™ Infectious Substance Packaging Product Portfolio
- 4.8.5 Therapak™ Recent Developments
- 4.9 Serpac
- 4.9.1 Serpac Company Information
- 4.9.2 Serpac Business Overview
- 4.9.3 Serpac Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Serpac Infectious Substance Packaging Product Portfolio
- 4.9.5 Serpac Recent Developments
- 4.10 Friobox
- 4.10.1 Friobox Company Information
- 4.10.2 Friobox Business Overview
- 4.10.3 Friobox Infectious Substance Packaging Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Friobox Infectious Substance Packaging Product Portfolio
- 4.10.5 Friobox Recent Developments
5 Global Infectious Substance Packaging Market Scenario by Region
- 5.1 Global Infectious Substance Packaging Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Infectious Substance Packaging Sales by Region: 2021-2032
- 5.2.1 Global Infectious Substance Packaging Sales by Region: 2021-2026
- 5.2.2 Global Infectious Substance Packaging Sales by Region: 2027-2032
- 5.3 Global Infectious Substance Packaging Revenue by Region: 2021-2032
- 5.3.1 Global Infectious Substance Packaging Revenue by Region: 2021-2026
- 5.3.2 Global Infectious Substance Packaging Revenue by Region: 2027-2032
- 5.4 North America Infectious Substance Packaging Market Facts & Figures by Country
- 5.4.1 North America Infectious Substance Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Infectious Substance Packaging Sales by Country (2021-2032)
- 5.4.3 North America Infectious Substance Packaging Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Infectious Substance Packaging Market Facts & Figures by Country
- 5.5.1 Europe Infectious Substance Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Infectious Substance Packaging Sales by Country (2021-2032)
- 5.5.3 Europe Infectious Substance Packaging Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Infectious Substance Packaging Market Facts & Figures by Country
- 5.6.1 Asia Pacific Infectious Substance Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Infectious Substance Packaging Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Infectious Substance Packaging Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Infectious Substance Packaging Market Facts & Figures by Country
- 5.7.1 South America Infectious Substance Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Infectious Substance Packaging Sales by Country (2021-2032)
- 5.7.3 South America Infectious Substance Packaging Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Infectious Substance Packaging Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Infectious Substance Packaging Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Infectious Substance Packaging Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Infectious Substance Packaging Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Infectious Substance Packaging Sales by Type (2021-2032)
- 6.1.1 Global Infectious Substance Packaging Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Infectious Substance Packaging Sales Market Share by Type (2021-2032)
- 6.2 Global Infectious Substance Packaging Revenue by Type (2021-2032)
- 6.2.1 Global Infectious Substance Packaging Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Infectious Substance Packaging Revenue Market Share by Type (2021-2032)
- 6.3 Global Infectious Substance Packaging Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Infectious Substance Packaging Sales by Application (2021-2032)
- 7.1.1 Global Infectious Substance Packaging Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Infectious Substance Packaging Sales Market Share by Application (2021-2032)
- 7.2 Global Infectious Substance Packaging Revenue by Application (2021-2032)
- 7.2.1 Global Infectious Substance Packaging Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Infectious Substance Packaging Revenue Market Share by Application (2021-2032)
- 7.3 Global Infectious Substance Packaging Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Infectious Substance Packaging Value Chain Analysis
- 8.1.1 Infectious Substance Packaging Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Infectious Substance Packaging Production Mode & Process
- 8.2 Infectious Substance Packaging Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Infectious Substance Packaging Distributors
- 8.2.3 Infectious Substance Packaging Customers
9 Global Infectious Substance Packaging Analyzing Market Dynamics
- 9.1 Infectious Substance Packaging Industry Trends
- 9.2 Infectious Substance Packaging Industry Drivers
- 9.3 Infectious Substance Packaging Industry Opportunities and Challenges
- 9.4 Infectious Substance Packaging Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst